Predictive Oncology Inc. - PE Ratio
POAI
Price:
$4.91
Market Cap:
$24.16M
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics division offers extensive clinical diagnostic services, including tumor drug response assessments and genomic profiling, alongside contract research focused on patient-centered drug discovery. This latter service leverages active learning technology for foundational discovery, clinical and translational research, clinical trials, and the developme...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2010-05-03
Stock Exchange
NASDAQ
Ticker
POAI
PE Ratio
[-0.03]
ROE
[-10705.18%]
Current Ratio
[8.89]
Dividend Yield
[0%]
Enterprise Value
[18.67M]
Dividend History
The PE Ratio as of June 2026 (TTM) for Predictive Oncology Inc. (POAI) is -0.03
According to Predictive Oncology Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -99.06% compared to the average of -3.68 of the last 4 quarters.
Predictive Oncology Inc. (POAI) Historical PE Ratio (quarterly & annually)
How has POAI PE Ratio performed in the past?
The mean historical PE Ratio of Predictive Oncology Inc. over the last ten years is -13.00. The current -0.03 PE Ratio has changed -73.27% with respect to the historical average. Over the past ten years (40 quarters), POAI's PE Ratio was at its highest in in the June 2019 quarter at 47.40. The PE Ratio was at its lowest in in the June 2021 quarter at -98.25.
Average
-13.00
Median
-12.50
Minimum
-39.89
Maximum
-0.53
Predictive Oncology Inc. (POAI) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Predictive Oncology Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 703.76%
Maximum Annual PE Ratio = -0.53
Minimum Annual Increase = -97.47%
Minimum Annual PE Ratio = -39.89
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.53 | -90.26% |
| 2024 | -5.49 | -61.28% |
| 2023 | -14.18 | 7.47% |
| 2022 | -13.19 | -66.92% |
| 2021 | -39.89 | 703.76% |
| 2020 | -4.96 | -13.08% |
| 2019 | -5.71 | -51.61% |
| 2018 | -11.80 | -26.53% |
| 2017 | -16.06 | -11.63% |
| 2016 | -18.17 | -97.47% |
Predictive Oncology Inc. (POAI) Average PE Ratio
How has POAI PE Ratio performed in the past?
The current PE Ratio of Predictive Oncology Inc. (POAI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.74
5-year avg
-14.66
10-year avg
-13.00
Predictive Oncology Inc. (POAI) PE Ratio vs. Peers
How is POAI’s PE Ratio compared to its peers?
Predictive Oncology Inc.’s PE Ratio is greater than Mainz Biomed B.V. (-4.09), greater than Bionano Genomics, Inc. (-0.20), greater than VYNE Therapeutics Inc. (-1.31), greater than Pasithea Therapeutics Corp. (-0.21), greater than GBS Inc. (-0.18), greater than Alaunos Therapeutics, Inc. (-0.99), greater than HeartSciences Inc. (-0.37), greater than Cyclerion Therapeutics, Inc. (-2.25), greater than AIM ImmunoTech Inc. (-0.21), greater than Autonomix Medical, Inc. Common Stock (-0.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.09 | $14.69M | |
| -0.20 | $13.08M | |
| -1.31 | $10.59M | |
| -0.21 | $3.72M | |
| -0.18 | $433.58K | |
| -0.99 | $5.25M | |
| -0.37 | $3.99M | |
| -2.25 | $13.86M | |
| -0.21 | $1.29M | |
| -0.12 | $1.87M |
Build a custom stock screener for Predictive Oncology Inc. (POAI) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Predictive Oncology Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Predictive Oncology Inc. (POAI) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Predictive Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Predictive Oncology Inc.'s PE Ratio?
How is the PE Ratio calculated for Predictive Oncology Inc. (POAI)?
What is the highest PE Ratio for Predictive Oncology Inc. (POAI)?
What is the 3-year average PE Ratio for Predictive Oncology Inc. (POAI)?
What is the 5-year average PE Ratio for Predictive Oncology Inc. (POAI)?
How does the current PE Ratio for Predictive Oncology Inc. (POAI) compare to its historical average?